Thierry Lecomte Selected Research

Thierry Lecomte Research Topics

Disease

61	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 08/2002
41	Neoplasms (Cancer) 01/2024 - 08/2002
18	Adenocarcinoma 01/2024 - 12/2014
13	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2005
9	Pancreatic Neoplasms (Pancreatic Cancer) 11/2022 - 06/2002
6	Colonic Neoplasms (Colon Cancer) 02/2024 - 12/2009
6	Neutropenia 01/2024 - 01/2010
6	Rectal Neoplasms (Rectal Cancer) 04/2022 - 08/2019
5	Microsatellite Instability 05/2022 - 07/2016
5	Crohn Disease (Crohn's Disease) 01/2022 - 11/2003
5	Stomach Neoplasms (Stomach Cancer) 01/2022 - 04/2016
3	Thrombocytopenia (Thrombopenia) 01/2024 - 01/2017
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2024 - 02/2021
3	COVID-19 02/2023 - 01/2020
3	Disease Progression 01/2022 - 10/2011
3	Hepatocellular Carcinoma (Hepatoma) 03/2021 - 12/2008
2	Asthenia 01/2024 - 03/2021
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2022 - 09/2015
2	Ankylosing Spondylitis 01/2022 - 10/2016
2	Rheumatoid Arthritis 01/2022 - 10/2016
2	Neuroendocrine Carcinoma 06/2020 - 10/2015
2	Mucositis 12/2019 - 01/2017
2	Fatigue 12/2019 - 01/2017
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 10/2019 - 02/2015
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 05/2006 - 04/2005
1	Anemia 01/2024
1	Adenosquamous Carcinoma 01/2023
1	Frailty 01/2022
1	Cachexia 01/2022
1	Necrosis 01/2022
1	Primitive Neuroectodermal Tumors (PNET) 01/2022
1	Sarcopenia 11/2021
1	Esophageal Stenosis (Esophageal Stricture) 09/2021
1	Liver Failure 03/2021

Drug/Important Bio-Agent (IBA)

13	Fluorouracil (Carac)FDA LinkGeneric 01/2024 - 06/2002
12	Gemcitabine FDA Link 01/2024 - 06/2002
12	Monoclonal AntibodiesIBA 01/2022 - 10/2009
10	Bevacizumab (Avastin)FDA Link 12/2023 - 12/2008
10	Cetuximab (Erbitux)FDA Link 01/2023 - 09/2008
9	Irinotecan (Camptosar)FDA LinkGeneric 01/2024 - 01/2010
7	Biomarkers (Surrogate Marker)IBA 01/2023 - 03/2015
7	Leucovorin (Folinic Acid)FDA Link 12/2020 - 06/2002
6	ErbB Receptors (EGF Receptor)IBA 01/2023 - 10/2009
6	folfirinoxIBA 11/2022 - 09/2015
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2024 - 05/2006
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2013
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2023 - 11/2016
4	CalciumIBA 05/2022 - 06/2016
4	130-nm albumin-bound paclitaxelIBA 09/2019 - 09/2015
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024 - 03/2021
3	Carcinoembryonic AntigenIBA 12/2023 - 11/2016
3	afliberceptIBA 12/2022 - 01/2020
3	Immune Checkpoint InhibitorsIBA 04/2022 - 01/2021
3	RamucirumabIBA 01/2022 - 01/2018
3	Infliximab (Remicade)FDA Link 01/2022 - 12/2015
3	Sunitinib (Sutent)FDA Link 01/2022 - 12/2008
3	Circulating Tumor DNAIBA 12/2021 - 07/2019
3	PlatinumIBA 06/2020 - 09/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2024 - 01/2022
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 08/2002
2	Calcibiotic Root Canal SealerIBA 04/2022 - 08/2017
2	Calcium Channels (Calcium Channel)IBA 01/2022 - 04/2019
2	Everolimus FDA Link 01/2022 - 12/2019
2	AerosolsIBA 01/2022 - 09/2021
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2022 - 02/2021
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 06/2002
2	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 01/2022 - 04/2019
2	BilirubinIBA 03/2021 - 12/2014
2	Panitumumab (Vectibix)FDA Link 01/2021 - 02/2018
2	Angiopoietin-2IBA 10/2020 - 03/2015
2	eryaspaseIBA 05/2020 - 01/2020
2	EnzymesIBA 12/2019 - 06/2004
2	Indigo Carmine (Indigo Blue)IBA 10/2019 - 02/2015
2	Matrix Metalloproteinases (MMPs)IBA 04/2005 - 01/2005
1	spleen fibrinolytic proteinase (human) (SFP)IBA 02/2024
1	Radioisotopes (Radionuclides)IBA 01/2024
1	lutetium Lu 177 dotatateIBA 01/2024
1	Peptide Receptors (Peptide Receptor)IBA 01/2024
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2024
1	A-factor (Streptomyces)IBA 01/2024
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	CurcuminIBA 05/2022
1	encorafenibIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	PotassiumIBA 01/2022
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2022
1	UbiquitinIBA 01/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022
1	pembrolizumabIBA 10/2021
1	HydrogelsIBA 09/2021

Therapy/Procedure

39	Drug Therapy (Chemotherapy) 01/2024 - 09/2004
22	Therapeutics 01/2024 - 06/2002
4	Neoadjuvant Therapy 04/2022 - 06/2020
3	Adjuvant Chemotherapy 01/2023 - 07/2016
3	Chemoradiotherapy 01/2021 - 10/2015
2	Continuity of Patient Care 02/2023 - 12/2022
2	Microbubbles 01/2022 - 01/2019
1	Immunotherapy 04/2022
1	Enhanced Recovery After Surgery 01/2022
1	Aftercare (After-Treatment) 01/2022